{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:43:31Z","timestamp":1791085411104,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["patient-research.elsevier.com","annalspathology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.anndiagpath.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T03:31:15Z","timestamp":1392953475000},"page":"140-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma"],"prefix":"10.1016","volume":"18","author":[{"given":"Anne S.","family":"Tsao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Harun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikki","family":"Devito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jack","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waun Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Suraokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0005","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0010","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3816\/CLC.2009.n.005","article-title":"Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma","volume":"10","author":"Tsao","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0025","doi-asserted-by":"crossref","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol;12:763\u201372.","DOI":"10.1016\/S1470-2045(11)70149-8"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0035","doi-asserted-by":"crossref","unstructured":"Flores RM, Riedel E, Donington JS, et al. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol;5:1649\u201354.","DOI":"10.1097\/JTO.0b013e3181f1903e"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0040","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnci\/djp061","article-title":"Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma","volume":"101","author":"Gordon","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-895X(25)09719-6","article-title":"Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme","volume":"46","author":"Dorai","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1432-1033.1992.tb17223.x","article-title":"Splicing of the platelet-derived-growth-factor A-chain mRNA in human malignant mesothelioma cell lines and regulation of its expression","volume":"208","author":"Langerak","year":"1992","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0055","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1165\/ajrcmb.24.6.4334","article-title":"Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo","volume":"24","author":"Metheny-Barlow","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<151::AID-PATH425>3.0.CO;2-E","article-title":"Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo","volume":"178","author":"Langerak","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1711670102","article-title":"Immunoreactivity for the beta chain of the platelet-derived growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium","volume":"167","author":"Ramael","year":"1992","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0070","first-page":"613","article-title":"Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions","volume":"39","author":"Ascoli","year":"1995","journal-title":"Acta Cytol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0075","first-page":"2005","article-title":"Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors","volume":"6","author":"Versnel","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/thx.2007.085241","article-title":"EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors","volume":"63","author":"Kothmaier","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1006542301794","article-title":"Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction","volume":"16","author":"Klominek","year":"1998","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0090","doi-asserted-by":"crossref","unstructured":"Behrens C, Feng L, Kadara H, et al. Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions. Clin Cancer Res;16:34\u201344.","DOI":"10.1158\/1078-0432.CCR-09-0650"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0095","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/jcp.2009.066548","article-title":"EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer","volume":"62","author":"Varella-Garcia","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/modpathol.2009.43","article-title":"CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas","volume":"22","author":"Soares","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0105","series-title":"Statistical methods, 7th edition","author":"Snedecor","year":"1980"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00031305.1997.10474412","article-title":"A versatile one-dimenstional distribution plot: the BLiP plot","volume":"51","author":"Lee","year":"1997","journal-title":"Am Stat"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimator from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0120","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0130","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1172\/JCI31334","article-title":"Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content","volume":"117","author":"McCarty","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0135","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1073\/pnas.81.8.2396","article-title":"Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents","volume":"81","author":"Bowen-Pope","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000087376","article-title":"Serum PDGF-AB in pleural mesothelioma","volume":"26","author":"Filiberti","year":"2005","journal-title":"Tumour Biol"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0145","doi-asserted-by":"crossref","first-page":"e3794","DOI":"10.1371\/journal.pone.0003794","article-title":"Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells","volume":"3","author":"Wu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0150","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/carcin\/bgp097","article-title":"Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells","volume":"30","author":"Kawaguchi","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.anndiagpath.2014.02.005_bb0155","doi-asserted-by":"crossref","unstructured":"Perrone F, Jocolle G, Pennati M, et al. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma. Eur J Cancer;46:2837\u201348.","DOI":"10.1016\/j.ejca.2010.06.130"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913414000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913414000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T22:11:47Z","timestamp":1746137507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913414000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1092913414000100"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2014.02.005","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}